Frontiers in Allergy (Oct 2024)

Diagnosis and management of shrimp allergy

  • Bin Brenda Su,
  • Warren Blackmon,
  • Chun Xu,
  • Christopher Holt,
  • Nathaniel Boateng,
  • Darren Wang,
  • Vibha Szafron,
  • Aikaterini Anagnostou,
  • Sara Anvari,
  • Carla M. Davis

DOI
https://doi.org/10.3389/falgy.2024.1456999
Journal volume & issue
Vol. 5

Abstract

Read online

Shrimp allergy, the most common food allergy in the United States, affects up to 2% of the population. Its etiology is multi-factorial with the combination of genetic predisposition and environmental exposures. This review summarizes the latest diagnosis and management strategies for shrimp allergy. Currently, the double-blind, placebo-controlled food challenge is the gold standard for diagnosis. Moreover, mainstream and experimental management strategies include food allergen avoidance, the FDA-approved omalizumab, and oral immunotherapy. Herein, we emphasize the urgent need to develop more effective diagnostic tools and therapies for shrimp allergy.

Keywords